In order to improve cutting-edge knowledge on Rare Hematological Diseases (RHD), ERN-EuroBloodNet has identified across Europe the healthcare areas including highly specialized procedures requiring preceptorship for the acquisition of medical expertise. First interventional healthcare area identified is: Inherited and acquired bone marrow failures including Aplastic Anaemia (AA) and Paroxysmal Nocturnal Hemoglobinuria (PNH) in adult and pediatric patients.
ERN-EuroBloodNet is endorsing three preceptorships held in ERN-EuroBloodNet highly specialized centers for AA and PNH with the objective to provide applicants with the fundamental tools for a correct diagnostic and treatment approach to bone marrow failures, including AA and PNH in children, adolescents and adult patients.
The highly specialized centers hosting preceptorships are ERN-EuroBloodNet members that represent the excellence in RHD field at International level.
The three preceptorships will bring together a maximum of 12 participants (4 participants for each highly specialized host center), covering the following topics:
This call for participant is addressed to hematologist (age limit: 45 years) residing in a European Member States different from the country where the preceptorship is received.